Evolution was the force behind the decision to spin-off one of drug distributor Cardinal Health’s two divisions, according to CEO Kerry Clark in an article that appeared in Columbus Business First. The spinoff -announced in September -is expected to be completed by June.
 
The restructuring turned an organization that was operating as several different companies under one umbrella into a more cohesive organization. The split made sense based on the two focuses: The Healthcare Supply Chain Services distributes drugs and supplies; Clinical and Medical Products researches and produces infusion pumps and drug-dispensing systems.
 
 “The overall idea of separating the company along those lines was simply so compelling,”Director John Finn said for the article. “It was not a heated debate.”